Source: AeroSafe Blog

AeroSafe Blog Efficiencies with Personalized Medicine: Just-In-Time Delivery

Over the past two decades, personalized medicine has evolved from a scientific vision to a standard of care for various disease states. With the expanding knowledge in genetics and genomics, precision therapies for cancers and chronic illnesses have advanced. As the shift from one-size-fits-all medicines to personalized treatments based on a person's unique genetic makeup has accelerated, distribution and delivery models are also changing.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Jay McHarg's photo - CEO of AeroSafe

CEO

Jay McHarg

CEO Approval Rating

87/100

Read more